A Prescriptive Analytics Framework for Optimal Policy Deployment Using Heterogeneous Treatment Effects

MIS Q. Pub Date : 2021-10-14 DOI:10.25300/misq/2021/15684
E. McFowland, Sandeep Gangarapu, R. Bapna, Tianshu Sun
{"title":"A Prescriptive Analytics Framework for Optimal Policy Deployment Using Heterogeneous Treatment Effects","authors":"E. McFowland, Sandeep Gangarapu, R. Bapna, Tianshu Sun","doi":"10.25300/misq/2021/15684","DOIUrl":null,"url":null,"abstract":"We define a prescriptive analytics framework that addresses the needs of a constrained decision-maker facing, ex ante, unknown costs and benefits of multiple policy levers. The framework is general in nature and can be deployed in any utility-maximizing context, public or private. It relies on randomized field experiments for causal inference, machine learning for estimating heterogeneous treatment effects, and on the optimization of an integer linear program for converting predictions into decisions. The net result is the discovery of individual-level targeting of policy interventions to maximize overall utility under a budget constraint. The framework is set in the context of the four pillars of analytics and is especially valuable for companies that already have an existing practice of running A/B tests. The key contribution of this work is to develop and operationalize a framework to exploit both within- and between-treatment arm heterogeneity in the utility response function in order to derive benefits from future (optimized) prescriptions. We demonstrate the value of this framework as compared to benchmark practices—i.e., the use of the average treatment effect, uplift modeling, as well as an extension to contextual bandits—in two different settings. Unlike these standard approaches, our framework is able to recognize, adapt to, and exploit the (potential) presence of different subpopulations that experience varying costs and benefits within a treatment arm while also exhibiting differential costs and benefits across treatment arms. As a result, we find a targeting strategy that produces an order of magnitude improvement in expected total utility for the case where significant within- and between-treatment arm heterogeneity exists.","PeriodicalId":18743,"journal":{"name":"MIS Q.","volume":"1 1","pages":"1807-1832"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MIS Q.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25300/misq/2021/15684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

We define a prescriptive analytics framework that addresses the needs of a constrained decision-maker facing, ex ante, unknown costs and benefits of multiple policy levers. The framework is general in nature and can be deployed in any utility-maximizing context, public or private. It relies on randomized field experiments for causal inference, machine learning for estimating heterogeneous treatment effects, and on the optimization of an integer linear program for converting predictions into decisions. The net result is the discovery of individual-level targeting of policy interventions to maximize overall utility under a budget constraint. The framework is set in the context of the four pillars of analytics and is especially valuable for companies that already have an existing practice of running A/B tests. The key contribution of this work is to develop and operationalize a framework to exploit both within- and between-treatment arm heterogeneity in the utility response function in order to derive benefits from future (optimized) prescriptions. We demonstrate the value of this framework as compared to benchmark practices—i.e., the use of the average treatment effect, uplift modeling, as well as an extension to contextual bandits—in two different settings. Unlike these standard approaches, our framework is able to recognize, adapt to, and exploit the (potential) presence of different subpopulations that experience varying costs and benefits within a treatment arm while also exhibiting differential costs and benefits across treatment arms. As a result, we find a targeting strategy that produces an order of magnitude improvement in expected total utility for the case where significant within- and between-treatment arm heterogeneity exists.
使用异构治疗效果的最优政策部署的规定性分析框架
我们定义了一个规定性的分析框架,以解决受约束的决策者面临的需求,事先,未知的成本和多种政策杠杆的收益。该框架本质上是通用的,可以部署在任何效用最大化的上下文中,无论是公共的还是私有的。它依靠随机现场实验来进行因果推理,依靠机器学习来估计异质治疗效果,依靠整数线性程序的优化来将预测转化为决策。最终的结果是发现在预算约束下,政策干预的个人层面目标是最大化总体效用。该框架是在分析的四大支柱的背景下设置的,对于已经有运行A/B测试的现有实践的公司尤其有价值。这项工作的关键贡献是开发和实施一个框架,以利用效用反应函数中治疗组内和治疗组之间的异质性,以便从未来(优化)处方中获益。与基准实践相比,我们演示了该框架的价值。在两种不同的设置中,使用平均处理效果,提升建模,以及扩展到上下文强盗。与这些标准方法不同,我们的框架能够识别、适应和利用不同亚群的(潜在)存在,这些亚群在治疗组内经历不同的成本和收益,同时也显示出不同治疗组的成本和收益差异。因此,我们发现了一种靶向策略,在治疗组内部和治疗组之间存在显著异质性的情况下,该策略可以提高预期总效用的数量级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信